Upload
delilah-gregory
View
218
Download
1
Tags:
Embed Size (px)
Citation preview
Harmonization of the UAE Clinical Trial Regulation and Ethical Approval
Dr. Mahera Abdulrahman, MD, MSc, PhDResearch Support SectionDubai Health Authority
Institutional Review Board (IRB)
• The International Council on Harmonization (ICH) defines an institutional review board (IRB) as:
“ A group formally designated to protect the rights, safety and well-being of humans involved in a clinical trial by reviewing all aspects of the trial and approving its startup. IRBs can also
be called independent ethics committees (IECs)”
Evolution of Research Ethics
• 1932 "Tuskegee Study of Untreated Syphilis“• 1947 Nuremburg Code• 1948 UN Universal Declaration of Human Rights• 1964 Declaration of Helsinki• 1979 Belmont Report• 1993 CIOMS: International Ethical Guidelines
for Biomedical Research (Updated 2002)• 1997 ICHTR: The International Conference on
Harmonisation of Technical Requirements for Registration of Pharmaceuticals
for Human Use
Nuremburg Code, 1947• Voluntary consent is absolutely essential• Good study design• Avoid unnecessary suffering• Death or serious injury should not be expected
outcome• Risk weighted against importance of the problem• Facilities and means to protect subject• Scientific qualification of researcher• Subject must be free to withdraw at any time• Be able to stop the study at any time
The Belmont Report, 1979• Autonomy, Respect for Persons:
Each individual: Has the right and capacity to decide; Has value and dignity; and Has the right to informed consent.
• Beneficence/ Do Good & Non-Maleficence/ Do No Harm:
Researchers must Protect the physical, mental & social well-being of each research participant Minimizes physical and social risks Maximize the possible benefits
• Justice/Non-Exploitation The research should generate more good than harm
Optimizing IRB Review: Principles and Potential Models• Historically IRBs• Large academic institutions conducted human research• Established as a local, institutional body • Single-site research predominated
• Evolving research landscape• Research increasingly a collaborative enterprise
• Growing prominence of multi-site trials• Central and other models of IRB review increasingly attractive• Efficiency• Consistency
• UK: • One multicentre IRB/REC would review the protocol and the
local IRBs would limit their review to locality issues, with an aim to communicate the decision to the applicant within three weeks (1998)
• France:• A single IRB/REC opinion has been in place since 1988
• Spain:• 133 RECs (local and regional) on 2005
Optimizing IRB Review: Principles and Potential Models
Optimizing IRB Review: Principles and Potential Models• EU, the Directive 2001/20/EC2 :To ensure legally the implementation of the principles of good clinical practice in clinical trials on medicinal products in Europe. This Directive does not apply to non-interventional trials. The whole process should take no longer than 60 days.
• US: The Common Rule is a rule of ethics regarding biomedical and behavioral research involving human subjects in the United States. These regulations governing IRBs for oversight of human research came into effect in 1981
IRB Guidelines in Middle EastCountry Entity Year/
Guidelines
UAE Ministry of Health 2006
Qatar Ministry of Health 2009
Bahrain Ministry of Health 2009
Kuwait Kuwait Institute for medical Specialization 2001
Saudi Arabia Saudi Food & Drug AuthoritySaudi Council for Health Specialties
20051998
Jordan Prime Ministers Council 2001
Egypt Ministry of Health 2003
Lebanon Perlman Council 1994
Alahmad et al. BMC Medical Ethics 2012, 13:34 Page 4 of 10
UAE Medical Liability Law No. 10 (2008)
• It shall be prohibited to conduct medical research or experiments on humans unless after obtaining the necessary license from one of the following bodies, as per their jurisdiction:
1. Dubai Health Authority2. Dubai Healthcare City Authority3. Ministry of Health 4. Health Authority – Abu Dhabi 5. Public universities
بعد” إال اإلنسان على طبية تجارب أو أبحاث إجراء يحظرالالئحة تحددها التي الجهة من بذلك ترخيص على الحصول
“ الالئحة تلك تقررها التي للشروط تبعا و التنفيذية
IRB in UAE
Each established research policies & standards
These regulatory activities are designed to: Ensure patient safety and the protection of research
subjects. Maintain the highest standards of ethical research conduct
consistent with international principles. Comply by all UAE laws, policies and regulations Conform to ICH-GCP standards Investigational New Drugs must be registered with The
Ministry of Health Drug Control Department and Each organization Drug and Medical Products Regulation Section.
IRB in UAE Health Authority – Abu Dhabi :
Governance structure to oversee regulation of human subjects research
Be limited to those licensed facilities that have been authorized to conduct research
Harmonizing the IRBs in UAE• Heterogeneity in terms of requirements and evaluations, patient
information and consent document, and investigator qualifications.
• The application requirements and processes are different, which results of loads of paper work and consumes time of researchers
• There are some discrepancies in the approaches of different ethics committees as regards inclusion and exclusion criteria
• Some ethics committees require applicants to have certificates in research (e.g. GCP)
• Some require payments
• Administrative burden is one main bottleneck in the process of seeking ethics approval: 4 weeks to sometimes months to get the approval
Harmonizing the IRBs in UAE
• This multiplication of effort is expensive, time consuming, and has resulted in too much variety in response among the IRBs involved
• There is a need for a common regulatory framework
• There is a need for formal training of ethics committee members
• Crucial need for specific training on innovative research and on highly specialized fields of research (somatic cell therapy, gene therapy, tissue bioengineering)
Harmonization should be sought intensively, in order to make the procedure more predictable and even quicker.
FUTURE SCOPES• Endorse effective and coordinated policies and regulations
for the conduct and oversight of clinical research
• Establishing, at the national level, a single electronic submission of the documents for clinical trials
• Maintain the integrity and enhance the effectiveness of institutional system
• Build partnerships and develop new mechanisms of interaction: regular meetings in a federal level
“Formally Establishing Central IRB in UAE”